MedPath

Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Conditions
Infective Endocarditis
Registration Number
NCT02388893
Lead Sponsor
University of Cologne
Brief Summary

As recommended in the Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (IE) patients with IE should be evaluated and managed by a multispecialty team including an cardiologist, infectious disease specialist, and cardiac surgeon. Our registry is a prospective, national registry of patients with IE. From January 2013 data from endocarditis board were prospectively recorded using standard definitions during the hospitalization. Patient demographics, clinical, laboratory, and imaging data at the time of IE diagnosis, as well as treatment outcomes were entered into the ER-UHC database.

Detailed Description

The primary endpoint will be the 1 year all-cause mortality after treatment begins of IE. We will use 1 year all-cause mortality as the primary endpoint because it has been demonstrated that a period of at least 6 months is necessary to offset the early postoperative mortality related to valve surgery. We also looked at all-cause in-hospital mortality as a secondary endpoint.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • All patients with patients with definitive infective endocarditis
Exclusion Criteria
  • childs

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All-cause mortality1 year

1-year all-cause mortality

Secondary Outcome Measures
NameTimeMethod
Inhospital all-cause mortality1 month

Trial Locations

Locations (1)

Heart Center of the University of Cologne

🇩🇪

Cologne, Germany

© Copyright 2025. All Rights Reserved by MedPath